CrushSCI.com
Journal Selection & Manuscript Polishing Services
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY journal cover Medicine
Back to journal directory

Review Cycle Records

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Taylor & Francis SCIE Non-OA
2026 Emerging Zone 42025 CAS Zone 42025 JCR Q3
166.9Average days
174Median days
38Fastest days
364Longest days
1672025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

38 days

Transformable nanosystems for cancer treatment

AuthorsHamed Morad; Reza Abdollahzadeh; Mostafa Rostamnezhad; Zahra Khademi; Negar Mottaghi-Dastjerdi; Khalil Abnous; Seyed Mohammad Taghdisi

Affiliations1. Department of Pharmaceutics and Pharmaceutical Nanotechnology, School of Pharmacy, Iran University of Medical Sciences; 2. Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences; 3. Nanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences; 4. Hematology Research Center, Shiraz University of Medical Sciences; 5. Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Iran University of Medical Sciences; 6. Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences; 7. Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences; 8. Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences; 9. Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences

Source PDF DOI Publisher page
62 days

Rosuvastatin–metformin co-processing: enhanced dissolution, oral bioavailability, and therapeutic efficacy through a solvent-minimized approach

AuthorsSoha M. El-Masry; Shaimaa K. Mostafa; Shaimaa M. Khedr; Abeer E. Abdelwahab; Sally A. Helmy

Affiliations1. Department of Pharmaceutics, Faculty of Pharmacy, Damanhour University; 2. Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Delta University for Science and Technology; 3. City of Scientific Research and Technological Applications (SRTA-City), Pharmaceutical and Fermentation Industries Development Centre (PFIDC); 4. Medical Biotechnology Department, Genetic Engineering Institute (GEBRI), City of Scientific Research and Technological Applications (SRTA-City); 5. Department of Pharmacy Practice, College of Pharmacy, Taibah University

Source PDF DOI Publisher page
199 days

Dual-drug-loaded lipid-based formulation for colon cancer therapeutics: in vitro optimization and characterization

AuthorsRushikesh Sanjay Shewale; Shyam Sudhakar Gomte; Jyoti Bishlay; Dimpal Suthar; Amit Kumar Pandey; Aakanchha Jain

Affiliations1. Department of Pharmaceutics, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), An Institute of National Importance, Government of India; 2. Department of Biotechnology, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), An Institute of National Importance, Government of India

Source PDF DOI Publisher page
100 days

Mitigating chemical degradation in amorphous and lipid-based formulations through cyclodextrin complexation and nanosizing

AuthorsStephie Lee; Preetanshu Pandey

Affiliations1. Boundless Bio, Chemistry, Manufacturing and Controls

Source PDF DOI Publisher page
204 days

Stimuli-responsive solid lipid nanoparticles for targeted drug delivery in biofilm-resistant infections: advances and challenges

AuthorsDakshinesh Parameswaran; Suriya Prakaash Kanan; Damodharan Narayanasamy

Affiliations1. Department of Pharmaceutics, SRM College of Pharmacy, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology

Source PDF DOI Publisher page
174 days

Rutin-enabled improved systemic exposure of doxorubicin via nanostructured lipid carriers: a proof of concept through novel LC-MS/MS analysis

AuthorsNeha Agarwal; Avijit Kumar Bakshi; Dilip Panwar; Patil Rohit Santosh; Prabhat Ranjan Mishra

Affiliations1. Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute; 2. Academy of Scientific and Innovative Research (AcSIR)

Source PDF DOI Publisher page
201 days

An in vivo study on extended-release formulation of buprenorphine in Sprague–Dawley rats

AuthorsMaryam Dibaei; Hoda Lavasani; Seyed Mohammad Iman Moezzi; Banafsheh Kiani-Dehkordi; Sanaz Jamshidfar; Mahdi Gholami; Nastaran Hosseinifar; Mohammadreza Rouini

Affiliations1. Biopharmaceutics and Pharmacokinetic Division, Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences; 2. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences; 3. Department of Applied Chemistry, Faculty of Chemistry, Islamic Azad University, Tehran-North Branch

Source PDF DOI Publisher page
153 days

On-site microfluidic analysis of combined and individual drug effects on breast cancer spheroids

AuthorsFranciele Flores Vit; Yu Tzu Wu; Eric Fujiwara; Hernandes F. Carvalho; Lucimara G. de la Torre

Affiliations1. Department of Materials and Bioprocesses Engineering, School of Chemical Engineering, University of Campinas; 2. School of Mechanical Engineering, Laboratory of Photonic Materials and Devices, University of Campinas; 3. Department of Structural and Functional Biology, Institute of Biology, University of Campinas

Source PDF DOI Publisher page
364 days

Preparation and characterization of pre-nanoemulsions encapsulating multiple oil-soluble active substances

AuthorsYuxin Liu; Zhenlin Shang; Wenxin Hu; Dongxu Liu; Jun Zhu; Xiaojing Pei; Ze Zhang

Affiliations1. School of Light Industry Science and Engineering, Beijing Technology and Business University

Source PDF DOI Publisher page
95 days

Synergistic anticancer potential of andrographolide and paclitaxel: a dose-reduction strategy to minimize toxicity and enhance therapeutic efficacy

AuthorsRomi Singh; Pooja Yadav; Dipti Srivastava; Nirupama Lal; Nishi Tandon; Mohini Chaurasia; S. J. S. Flora

Affiliations1. Department of Pharmacy, Era Medical College and University; 2. Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute; 3. Department of Pharmaceutics, Hygia Institute of Pharmaceutical Education and Research; 4. Department of Pathology, Era’s Lucknow Medical College and Hospital

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.